Showing results (11-20 of 232) with videos related to
Sort By:
Pageof 24
Current Opinion in Hematology|January 5, 2019
Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemiaMichael J MauroCurrent Opinion in Hematology|May 27, 2009
Appropriate sequencing of tyrosine kinase inhibitors in chronic myelogenous leukemia: when to change? A perspective in 2009Michael J MauroHematology. American Society of Hematology. Education Program|November 25, 2006
Defining and managing imatinib resistanceMichael J MauroCancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Tailoring tyrosine kinase inhibitor therapy in chronic myeloid leukemiaMichael J MauroCurrent Opinion in Hematology|January 19, 2017
Can any patients with chronic myeloid leukemia outside of a clinical trial have their tyrosine kinase inhibitor discontinued?Michael J MauroHematology. American Society of Hematology. Education Program|February 20, 2015
Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?Michael J MauroAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Overcoming resistance in chronic myelogenous leukemiaMichael J MauroClinical Lymphoma & Myeloma|June 16, 2009
Response dynamics in chronic-phase chronic myeloid leukemiaMichael J MauroLeukemia Research|September 11, 2013
Striving to achieve safe, permanent treatment discontinuation in chronic myeloid leukemiaMichael J MauroPageof 24